A look at Becton Dickinson & Co.’s (BDX) recent performance gives investors their first glimpse of hope.

On Friday, Becton Dickinson & Co. (NYSE: BDX) opened higher 1.42% from the last session, before settling in for the closing price of $240.33. Price fluctuations for BDX have ranged from $218.75 to $262.23 over the past 52 weeks.

Healthcare Sector giant saw their annual sales surged by 4.86% over the last five years. Company’s average yearly earnings per share was noted 7.38% at the time writing. With a float of $288.63 million, this company’s outstanding shares have now reached $290.39 million.

The firm has a total of 73000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 42.06%, operating margin of 11.79%, and the pretax margin is 8.44%.

Becton Dickinson & Co. (BDX) Insider Activity

A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Becton Dickinson & Co. is 0.14%, while institutional ownership is 89.93%. The most recent insider transaction that took place on Sep 16 ’24, was worth 94,312. Before that another transaction happened on Jun 10 ’24, when Company’s SVP,Controller&Chief Acct Off sold 300 for $239.31, making the entire transaction worth $71,793. This insider now owns 1,976 shares in total.

Becton Dickinson & Co. (BDX) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 7.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.00% during the next five years compared to 52.43% growth over the previous five years of trading.

Becton Dickinson & Co. (NYSE: BDX) Trading Performance Indicators

Check out the current performance indicators for Becton Dickinson & Co. (BDX). In the past quarter, the stock posted a quick ratio of 1.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.55. Likewise, its price to free cash flow for the trailing twelve months is 21.87.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.86, a number that is poised to hit 3.77 in the next quarter and is forecasted to reach 14.34 in one year’s time.

Technical Analysis of Becton Dickinson & Co. (BDX)

Analysing the last 5-days average volume posted by the [Becton Dickinson & Co., BDX], we can find that recorded value of 1.01 million was lower than the volume posted last year of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 68.06%. Additionally, its Average True Range was 3.73.

During the past 100 days, Becton Dickinson & Co.’s (BDX) raw stochastic average was set at 95.31%, which indicates a significant increase from 92.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 12.47% in the past 14 days, which was lower than the 17.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $236.90, while its 200-day Moving Average is $236.53. Now, the first resistance to watch is $245.18. This is followed by the second major resistance level at $246.62. The third major resistance level sits at $249.11. If the price goes on to break the first support level at $241.26, it is likely to go to the next support level at $238.77. Should the price break the second support level, the third support level stands at $237.34.

Becton Dickinson & Co. (NYSE: BDX) Key Stats

There are currently 289,006K shares outstanding in the company with a market cap of 70.45 billion. Presently, the company’s annual sales total 19,372 M according to its annual income of 1,484 M. Last quarter, the company’s sales amounted to 4,990 M and its income totaled 487,000 K.